Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |||
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||
Breast cancer | x | x | x | |||
Breast disorder | x | x | x | x | ||
Erythema multiforme | x | x | x | x | ||
Erythema nodosum | x | x | x | x | ||
Gallbladder disorder | x | x | x | x | ||
Gastrointestinal disorder | x | x | x | x | ||
Chloasma | x | x | x | x | ||
Myocardial infarction | x | x | x | x | ||
Nausea | x | x | x | x | ||
Neoplasm | x | x | x | x | ||
Pain | x | x | x | x | ||
Pruritus | x | |||||
Pulmonary embolism | x | x | x | x | ||
Cerebrovascular accident | x | x | x | x | ||
Malnutrition | x | x | x | x | ||
Fluid retention | x | x | x | x | ||
Endometrial cancer | x | x | x | x | ||
Dementia | x | x | x | x | ||
Application site irritation | x | x | ||||
Pelvic venous thrombosis | x | x | x | x | ||
Cervical discharge | x | x | x | x | ||
Breast cancer invasive NOS | x | x | x | x | ||
Breast discomfort | x | x | x | x | ||
Breast tension | x | |||||
Postmenopausal spotting | x | x | x | x | ||
Vascular purpura | x | x | ||||
Venous thromboembolism | x | x | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |